good miss revenu growth expect reduc full
buy-back plan risk/reward could becom interest favor
comparison huge buy-back limit downsid howev execut good
visibl low maintain market perform p-t
constant currenc revenu growth came consensu
expect rel model practic everi revenu line came
expect except academic/govern y/i china y/i
pharma y/i industri y/i ta y/i us flat y/i europ
y/i weaker expect constant currenc basi manag cite
on-going weak india weak demand european pharma custom ta
shipment time primari driver miss page full detail
gross margin flat y/i forecast consensu
off-set lower expect sg drove non-gaap oper
margin forecast ep came
forecast consensu rel model lower expect non-
oper expens share count ad ep
manag reduc revenu growth ep guidanc y/i cc
respect guidanc revenu ep
also well prior expect
manag announc acceler buy-back program plan achiev
net debt/ebitda target estim impli total share
repurchas well prior expect accordingli materi
increas beyond ep forecast despit reduc near long term
organ revenu growth forecast increas expect fx revenu growth
headwind
base revis increas ep estim current trade
price-to-earnings discount peer believ acknowledg discount
valuat warrant point given organ revenu growth track
deceler third consecut year period acceler peer growth
miss past quarter continu page
pleas see page report import disclosur
past month organ revenu growth deceler
peer group averag manag significantli increas pace invest
buyback yet result revenu growth acceler favor
comparison head materi buy-back program discount valuat
rel peer limit downsid howev see urgenc purchas
share given limit visibl core growth improv rate share market
perform price target
revenu growth improv
favor comparison
downsid ep estim limit
revenu growth acceler
driven favor comparison
new product
great cash flow return profil
macroeconom competit
current expect
limit room margin improv
continu slower expect growth
caus investor revisit inher
growth rate compani appropri
corpor analyt instrument manufactur
divis design manufactur sell servic high-perform liquid
chromatographi hplc ultra perform liquid chromatographi uplc togeth
hplc refer lc mass spectrometri ms instrument system support
product includ chromatographi column consum product post-
warranti servic plan ta divis ta compani primarili design
manufactur sell servic thermal analysi rheometri calorimetri instrument
compani also develop supplier software-bas product interfac
compani instrument well manufactur instrument
howev given price-to-earnings discount vs peer plan buy-back current
market cap see limit downsid risk accordingli risk/reward could
becom interest head favor comparison especi
becom clear new product may invigor organ revenu growth manag
state howev feel buy-back support share close
current level current feel urgent get involv today visibl core
improv remain low continu rate share market perform reduc
price target price-to-earnings dcf
compani report thomson eikon cowen compani
cowen vs consensu mm except cc re-affirmed fx y/i cc growth fx y/ygross re-affirmed oper fx revenu metric mm except statement mm except currenc expect ad ep pre-tax per count ep came expect consensu non-oper cost lower expect share count ad ep rel water divis revenu came forecast constant currenc revenu growth come expect end market pharma grew y/i cc industri grew y/i cc academic/govern grew y/i cc geographi asia grew y/i cc america grew y/i cc us flat y/i europ declin y/i cc overal recur revenu grew instrument flat y/i manag cite continu weak india weak demand among eu pharma custom ta revenu came forecast y/i cc growth expect instrument revenu declin y/i servic manag note order growth remain strong time shipment provid revenu headwind ta expect bounc back consensu organ constant currenc revenu growth came well consensu expect rel model practic everi revenu line expect except academic/govern revenu y/i china y/i portion miss due ta shipment time expect bounc back gross margin came expect consensu line model sg expect sale oper margin forecast driven entir sg off-set weaker expect gross margin larg line guidanc cowen
compani report cowen compani
mm except per share cagrcommentstot cc fx y/i cc growth fx currenc ex food growth impact y/i y/i impact cowen
compani report thomson eikon cowen compani
mm except cagrcommentsnet cc fx y/i cc growth fx y/yorgan currenc re-affirmed leverag sg grown revenu oper growth sale growth re-affirmed non-oper interest re-affirmed tax earn per fx headwind share dilut share count cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk upsid includ limit recoveri macroeconom condit
increas client budget demand lc/m instrument consum better
expect product innov associ revenu contribut share gain risk
downsid includ limit macroeconom deterior current
level inabl execut integr eros market share price due
competit inabl deliv incremental/decrement margin target value-
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc octob et dissemin octob et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
